Ridgeway Pharmacy Statement Regarding Website Security Incident Involving Third-Party Vendor

VICTOR, Mont., Sept. 21, 2026 /PRNewswire/ -- Ridgeway Pharmacy, Ltd. ("Ridgeway") is providing notice of an incident involving its pharmacy website, which was developed by a third-party vendor. Ridgeway identified operational issues on the website and promptly began an investigation with the assistance of external cybersecurity and forensic specialists. That investigation determined that a vulnerability in the vendor-supported website allowed an unknown third party to access the site using elevated privileges, and that certain information may have been accessible as a result. On August 21, 2026, Ridgeway determined that the information potentially involved may have included name, date of birth, address, prescription information, health information, insurance information, and, for a portion of the individuals, payment card information. Importantly, at no time did this incident involve Ridgeway's internal systems.

Ridgeway takes the privacy and security of information seriously and holds the third parties that support its services to that same standard. Upon learning of this matter, Ridgeway secured and remediated the affected website, stood up a new platform, further restricted access, strengthened monitoring, implemented additional protections against unauthorized activity, and reported the incident to federal law enforcement.

Written notice has been mailed to individuals whose information may have been involved, and out of an abundance of caution Ridgeway is offering complimentary identity protection services through TransUnion, a leading identity protection provider. As a general precaution, individuals are encouraged to review their account statements, health plan explanations of benefits, and credit reports for any unfamiliar activity, to enroll in the complimentary services described in their notification letter, and to report any unusual activity to their financial institution.

Individuals with questions may call Ridgeway's dedicated toll-free assistance line at 1-833-516-7133, available 8am – 8pm (ET).

SOURCE Ridgeway Pharmacy

Share this article

CINCINNATI, Sept. 21, 2026 /PRNewswire/ -- The Board of Directors of GE Aerospace (NYSE: GE) today declared a $0.47 per share dividend on the outstanding common stock of the Company. The dividend is payable October 26, 2026, to shareholders of record at the close of business on October 5, 2026. The ex-dividend date is October 5, 2026.

About GE Aerospace

GE Aerospace (NYSE: GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 50,000 commercial and 30,000 military aircraft engines. With a global team of approximately 57,000 employees building on more than a century of innovation and learning, GE Aerospace is committed to inventing the future of flight, lifting people up, and bringing them home safely. Learn more about how GE Aerospace and its partners are defining flight for today, tomorrow, and the future at www.geaerospace.com.

GE Aerospace's Investor Relations website at https://www.geaerospace.com/investor-relations and our corporate blog at https://www.geaerospace.com/news/articles, as well as GE Aerospace's social media accounts, contain a significant amount of information about GE Aerospace, including financial and other information for investors. GE Aerospace encourages investors to visit these websites from time to time, as information is updated and new information is posted.

SOURCE GE Aerospace

Share this article

TORONTO, Sept. 21, 2026 /PRNewswire/ -- Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) ("Sun Life") today announced its intention to redeem all of the outstanding $500 million principal amount of Series 2021-1 Subordinated Unsecured 2.46% Fixed/Floating Debentures (the "Debentures") in accordance with the redemption terms attached to the Debentures. The redemption will be funded from existing cash and liquid assets.

The Debentures are redeemable at Sun Life's option on or after November 18, 2026 at a redemption price per Debenture equal to the principal amount together with accrued and unpaid interest to the date of redemption. Sun Life intends to redeem the Debentures on November 18, 2026 (the "Redemption Date"). Notice will be delivered to the holders of the Debentures in accordance with the terms outlined in the trust indenture governing the Debentures.

After the Debentures are redeemed, interest will cease to accrue from and after the Redemption Date and holders of Debentures will not be entitled to exercise any rights as holders other than to receive the redemption price.

About Sun Life

Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the U.S., the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of June 30, 2026, Sun Life had total assets under management of $1.70 trillion. For more information, please visit www.sunlife.com.

Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.

Note to editors: All figures in Canadian dollars

Forward-Looking Statements

From time to time, Sun Life makes written or oral forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements contained in this release include, without limitation, statements relating to Sun Life's anticipated redemption of the Debentures. These statements represent our current expectations, estimates, and projections regarding future events and are not historical facts, and remain subject to change. Forward-looking statements are not a guarantee of future performance and involve risks and uncertainties that are difficult to predict. Information about forward-looking statements and risk factors relating to the Company are set out in our MD&A for the period ended June 30, 2026 and in Sun Life Financial Inc.'s other annual and interim regulatory filings filed with Canadian securities regulators or furnished to U.S. securities regulators, which are available for review at www.sedarplus.ca and www.sec.gov, respectively.

The Company does not undertake any obligation to update or revise its forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events, except as required by law.

To contact Sun Life media relations, please email [email protected].

To contact Sun Life investor relations, please email [email protected].

SOURCE Sun Life Financial Inc. - Financial News

Share this article

Upside Innovations Introduces FlowRail: The First Prefabricated Aluminum Guardrail That Adjusts in the Field

WEST CHESTER, Ohio, Sept. 21, 2026 /PRNewswire/ -- Upside Innovations, a SixAxis company and U.S. manufacturer of prefabricated aluminum access products, today announced FlowRail, a new patent-pending, OSHA-compliant aluminum guardrail system. One rail. Infinite possibilities. FlowRail is the first prefabricated guardrail that adjusts continuously in the field — across slopes, curves, corners, and grade changes — without slope-specific fittings, custom fabrication, or on-site welding.

A continuously adjustable base moves from 0° to 20°, so posts stay plumb on any ramp, walkway, or platform. Pivoting connections follow curves, corners, switchbacks, and grade changes — without splice castings, custom fittings, or shop drawings. One product line covers the run.

Order by the linear foot — no detailed drawings, no fitting takeoffs, no anticipating every angle. FlowRail ships with all the hardware and adjusts on site to match what's in front of you. Assembly uses basic hand tools; no welding or on-site fabrication. Plumb the posts, bolt it down, move on. Proudly designed and manufactured in West Chester, Ohio, FlowRail is in stock and ready to ship.

"Real ramps and walkways have slopes, curves, and corners. Most guardrail systems don't," said Kevin Sharp, President of Upside Innovations. "FlowRail is built for the job the site presents you with. One product covers the slope, the curve, the corner, and the grade change, and it bolts together without welding. That changes the math on installed cost and install time."

Key features

- The most adjustable guardrail ever built — 0°–20° base; pivoting connections for curves, corners, and switchbacks.

- Mounting options — Top mount for ramps and decks; side mount for vertical concrete or metal substrates.

- Easy installation — Bolts together. No field welding, no hot-work permits.

- 100% aluminum, long-lasting — 6061 / 6063 aluminum, mill or powder-coated.

- OSHA compliant — Meets OSHA 1910.29 and 1926.502.

- In stock, ready to ship — Domestic production, no tariff exposure.

Applications

Loading and dock ramps, equipment platforms, elevated walkways and catwalks, mezzanines, industrial stair landings and switchback runs, dock transitions, and outdoor pedestrian walkways.

Visit https://upsideinnovations.com/guardrails/ for more information.

About Upside Innovations

Upside Innovations is a designer and manufacturer of prefabricated aluminum access products — including ADA-compliant wheelchair ramps, ADA or OSHA code compliant metal stairs and platforms, guardrails, and covered walkways and canopies. Upside Innovations is a SixAxis company headquartered in West Chester, OH.

SOURCE SixAxis LLC

Share this article

COPENHAGEN, Denmark, Sept. 21, 2026 /PRNewswire/ -- Lightera today announced a major capital investment to expand its submarine optical fiber manufacturing operations in Denmark and the United States, reinforcing its commitment to meeting the rapidly growing global demand for submarine communications infrastructure. The expansion will nearly triple manufacturing capacity by 2029, ensuring reliable supply for existing customer commitments and future submarine cable programs.

The investment reflects continued strength in the submarine optical fiber market, driven by accelerating investment in artificial intelligence infrastructure, hyperscale data centers, cloud computing, and global network expansion. Lightera's direct relationships with submarine cable manufacturers and hyperscale companies provide early visibility into future demand and technology trends, as optical fiber is typically purchased approximately one year before cable deployment.

"As demand for global bandwidth continues to accelerate, the industry will require both greater manufacturing capacity and next-generation optical technologies," said Holly Hulse, Chief Executive Officer of Lightera. "This major expansion reflects our confidence in the long-term future of submarine communications and enables us to deliver both. It is part of a broader series of strategic investments Lightera is making across our global manufacturing footprint to expand capacity, advance next-generation technologies and support long-term customer demand. By expanding capacity today while preparing for multicore fiber, we are ensuring Lightera remains the partner of choice for customers building the next generation of global communications infrastructure."

The expansion also positions Lightera for the commercialization of multicore fiber (MCF), with initial submarine deployments expected in the 2029–2030 timeframe. This next-generation technology will significantly increase transmission capacity to support future global connectivity.

Lightera's facilities in Brøndby, Denmark, and Norcross, Georgia, United States, serve as the company's global manufacturing centers for submarine optical fiber, supplying high-performance optical fiber for some of the world's most demanding undersea communications networks.

About Lightera

Lightera is a global leader in optical fiber and connectivity solutions. Built on a legacy of expertise in optical science, we provide high-performance solutions that enable faster, more reliable, and sustainable connections for businesses, communities, and industries worldwide.

With operational headquarters in Norcross, Georgia, U.S.A., Lightera serves customers across telecommunications, enterprise, industrial, generative AI, data centers, 5G/6G, utilities, medical, aerospace, defense, and sensing markets.

Lightera is part of Furukawa Electric Group, a pioneer in advancing the next generation of infrastructure through integrated solutions in connectivity, information, energy, and mobility, to create a safe, peaceful, and sustainable world.

Please visit www.Lightera.com

SOURCE Lightera, LLC

Share this article

Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers

LOS ANGELES and NEW YORK, Sept. 21, 2026 /PRNewswire/ -- Paramount Skydance Corporation (NASDAQ: PSKY) ("Paramount") today announced the extension of the Expiration Dates in connection with the previously announced (i) offers to purchase (the "Tender Offers" and each, a "Tender Offer") for cash, upon the terms and subject to the conditions set forth in the related offer to purchase (the "Offer to Purchase"), any and all of the identified notes in each series of the Existing Tender Offer Notes (defined by reference to the table set forth below) issued by Discovery Global Holdings, Inc. (formerly WarnerMedia Holdings, Inc.) (the "DGH Issuer") and Discovery Communications, LLC (the "DCL Issuer" and together with the DGH Issuer, each a "WBD Issuer" and collectively the "WBD Issuers"), as applicable, and (ii) offers to exchange (the "Exchange Offers" and each, an "Exchange Offer" and, together with the Tender Offers, the "Offers" and each, an "Offer"), upon the terms and subject to the conditions set forth in the related exchange offer memorandum (the "Offering Memorandum"), any and all of the identified notes in each series of the Existing Exchange Offer Notes (defined by reference to the table set forth below) (together with the Existing Tender Offer Notes, the "Offer Notes") issued by the applicable WBD Issuer for notes to be newly issued by Paramount.

The Expiration Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) have been extended to 5:00 p.m., New York City time, on October 2, 2026, unless further extended. The Settlement Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) will occur promptly after the Expiration Date and are currently anticipated to occur in the third quarter of 2026. Paramount anticipates extending the Expiration Date for such Tender Offers and Exchange Offers until such time that would result in the Settlement Dates occurring on or promptly following the closing date of the proposed acquisition (the "Acquisition") by Paramount of Warner Bros. Discovery, Inc. ("WBD"). Tenders of the Offer Notes in the Offers may be withdrawn at any time prior to the Expiration Date. The aforementioned extensions further extend the Expiration Dates previously extended by Paramount on June 12, 2026, June 26, 2026, July 13, 2026, July 17, 2026, July 24, 2026, July 31, 2026, August 7, 2026, August 17, 2026, August 24, 2026, August 31, 2026, September 8, 2026, and September 14, 2026.

As of 5:00 p.m., New York City time, on September 18, 2026, approximately 66.87% and 75.12% of the aggregate principal amount of the Existing Tender Offer Notes and Existing Exchange Offer Notes, respectively, have been validly tendered in the applicable Offers. As Paramount previously announced that it anticipates extending the Offers to align with the closing date of the Acquisition, Paramount does not view these figures to be representative of the final results of the applicable Offers.

Information about each series of Offer Notes eligible to participate in the Offers is summarized below.

The Exchange Offers are being made pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended (the "Securities Act"), and the rules and regulations of the Securities and Exchange Commission (the "SEC") promulgated thereunder, and are also not being registered under any state or foreign securities laws. Any securities offered pursuant to the Exchange Offers may not be offered or sold in the United States or to any U.S. persons (as defined below) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Exchange Offers will only be made, and the securities offered pursuant to the Exchange Offers are only being offered and issued, to holders of applicable Existing Exchange Offer Notes who are (a) reasonably believed to be "qualified institutional buyers" as defined in Rule 144A under the Securities Act or (b) not "U.S. persons," as defined in Rule 902 of Regulation S under the Securities Act (such holders, "Eligible Holders"), and only Eligible Holders who have completed and returned the eligibility certification are authorized to receive or review the Offering Memorandum or to participate in the Exchange Offers. The eligibility certification is available electronically at: https://gbsc-usa.com/eligibility/paramount.

General

Each Offer is a separate offer, and each may be individually consummated, amended, extended, terminated, or withdrawn, subject to certain conditions and applicable law, at any time in Paramount's sole discretion, and without also consummating, amending, extending, terminating, or withdrawing any other Offer with respect to any other series of Offer Notes. Paramount may terminate an Offer if any of the conditions of such Offer described in the Offer to Purchase or Offering Memorandum, as applicable, are not satisfied or waived by the applicable Expiration Date, subject to applicable law. In addition, Paramount may waive the conditions to an Offer without extending such Offer in accordance with applicable law.

The Offers are being made solely by Paramount and are not being made by WBD or the WBD Issuers. None of Paramount, WBD, the WBD Issuers, the Dealer Managers, the Exchange Agent (as defined below), the Information Agent (as defined below), the trustees under each of the indentures governing the Offer Notes, the trustee or collateral agent under the indenture that will govern the notes to be issued in the Exchange Offers, or any affiliate of any of them makes any recommendation as to whether any holder of Offer Notes should tender or refrain from tendering all or any portion of the principal amount of such holder's Offer Notes for cash or notes to be issued in the Exchange Offers. No one has been authorized by any of them to make such a recommendation. Holders must make their own decision whether to tender Offer Notes in any Offer and, if so, the amount of Offer Notes to tender.

Only Eligible Holders may receive a copy of the Offering Memorandum and participate in the Exchange Offers. Paramount has engaged Global Bondholder Services Corporation to act as the exchange agent (in such capacity, the "Exchange Agent") and information agent (in such capacity, the "Information Agent") for the Offers. Questions concerning the Offers, or requests for additional copies of the Offer to Purchase or Offering Memorandum or other related documents, may be directed to Corporate Actions by telephone at (855) 654-2014 (U.S. toll-free) or (212) 430-3774 (banks and brokers) or by email at [email protected]. Holders should also consult their broker, dealer, commercial bank, trust company or other institution for assistance concerning the Offers. The Exchange Offer documents and the Tender Offer documents can be accessed at the following link: https://gbsc-usa.com/paramount.

Paramount has engaged BofA Securities and Citigroup as dealer managers (in such capacity, the "Dealer Managers") for the Offers. Holders with questions regarding the Offers should contact BofA Securities, Inc. at +1 (888) 292-0070 (toll-free) or +1 (980) 388-3646 (collect) or [email protected] or Citigroup Global Markets Inc. at +1 (800) 558-3745 (toll-free) or +1 (212) 723-6106 or ny.liabilitymanagement@citi.com. Latham & Watkins LLP is serving as legal counsel to Paramount and Cahill Gordon & Reindel LLP is serving as legal counsel to the Dealer Managers.

This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security, and does not constitute an offer, solicitation, or sale of any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful.

About Paramount, a Skydance Corporation

Paramount, a Skydance Corporation is a next-generation global media and entertainment company, comprised of three business segments: Studios, Direct-to-Consumer, and TV Media. PSKY's portfolio unites legendary brands, including Paramount Pictures, Paramount Television, CBS, CBS News, CBS Sports, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount+, Pluto TV, and Skydance Animation, Film, Television, Interactive/Games, and Paramount Sports Entertainment.

PSKY-IR

Cautionary Note Concerning Forward-Looking Statements

This communication contains "forward-looking statements" regarding the Acquisition and the other transactions referred to herein. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Paramount.

PUNE, India, Sept. 21, 2026 /PRNewswire/ -- The Global Pharmaceutical Logistics Market Size was valued at approximately USD 100.0 Billion in 2025 and is projected to expand at a strong 7.7% CAGR from 2026 to 2034, reaching approximately USD 194.0 Billion by 2034.

Global Pharmaceutical Logistics Market

Global Pharmaceutical Logistics Market Report 2025 provides a comprehensive analysis of market trends, size, and forecasts through 2034. The industry is expanding alongside the growth of pharmaceutical manufacturing, international drug distribution, biologics, vaccines, and specialty medicines. Rising demand for cold-chain and temperature-controlled logistics is driving investments in refrigerated transportation, specialized warehousing, cold storage, and real-time temperature monitoring. Meanwhile, IoT-enabled monitoring, GPS tracking, digital shipment visibility, automated warehouse systems, and specialized pharmaceutical transportation are improving supply-chain control, traceability, and product integrity. The increasing role of third-party logistics providers is further supporting integrated pharmaceutical transportation, warehousing, inventory management, and distribution services across global markets.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.maximizemarketresearch.com/request-sample/108428/

Global Pharmaceutical Logistics Market expands with cold-chain infrastructure and digital supply chain solutions: Maximize Market Research unveils key insights.

Global Pharmaceutical Logistics Market Size & Forecast:

Pharmaceutical Logistics Market Trends & Insights:

- North America remains a significant regional market, supported by established pharmaceutical and biotechnology industries, advanced healthcare infrastructure, and sophisticated distribution networks.

- Asia-Pacific is emerging as an important growth center, driven by expanding pharmaceutical manufacturing, increasing healthcare expenditure, pharmaceutical exports, and developing distribution infrastructure.

- Cold-chain logistics is witnessing strong demand due to the growing distribution of biologics, vaccines, specialty medicines, and other temperature-sensitive pharmaceutical products.

- Digitalization of pharmaceutical logistics is accelerating through IoT-enabled monitoring, GPS tracking, real-time shipment visibility, track-and-trace systems, and digital supply-chain platforms.

- Third-party logistics providers are expanding their role by offering integrated transportation, warehousing, cold-chain, inventory management, order fulfillment, and distribution services.

Cold-Chain Expansion and Pharmaceutical Trade Drive Global Pharmaceutical Logistics Market Growth Opportunities

Global Pharmaceutical Logistics Market is gaining strong strategic momentum as pharmaceutical manufacturing, international drug distribution, biologics, vaccines, and specialty medicines expand across global healthcare supply chains. Rising demand for cold-chain and temperature-controlled logistics is increasing the need for refrigerated transportation, specialized warehousing, cold storage, and real-time temperature monitoring. The growing role of third-party logistics providers is further expanding Pharmaceutical Logistics Market Growth Opportunities through integrated transportation, inventory management, order fulfillment, and distribution services.

Temperature-Sensitive Products, Regulatory Compliance, and Supply-Chain Complexity Restrain Global Pharmaceutical Logistics Market Growth

Pharmaceutical Logistics Market faces operational challenges associated with maintaining product quality, regulatory compliance, and controlled environmental conditions throughout transportation and storage. Temperature-sensitive pharmaceuticals require validated cold-chain infrastructure, specialized handling, continuous monitoring, and reliable distribution networks. Complex cross-border pharmaceutical supply chains and the need for traceability can increase operational requirements, creating challenges for scalable logistics deployment across different regions.

Digital Tracking, IoT Monitoring, and Specialized Logistics Unlock Global Pharmaceutical Logistics Market Opportunities

Pharmaceutical logistics is entering a technology-driven transformation phase as IoT-enabled monitoring, GPS tracking, real-time shipment visibility, track-and-trace systems, and digital supply-chain platforms improve control across pharmaceutical distribution networks. Growing adoption of automated warehouse systems and digitally monitored transportation is strengthening traceability, inventory management, and shipment visibility. At the same time, increasing demand for biologics, vaccines, specialty medicines, and advanced therapies is creating Pharmaceutical Logistics Market Growth Opportunities for specialized logistics providers and integrated cold-chain solutions.

Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/request-sample/108428/

Cold-Chain Infrastructure, Digital Tracking, and Specialized Transportation Transform Global Pharmaceutical Logistics Market

Temperature-Controlled Logistics: Increasing volumes of biologics, vaccines, specialty medicines, and other temperature-sensitive pharmaceutical products are driving demand for refrigerated transportation, cold storage, specialized warehousing, and real-time temperature monitoring across global supply chains.

Digital Shipment Visibility: IoT-enabled monitoring, GPS tracking, track-and-trace systems, and digital supply-chain platforms are improving shipment visibility, traceability, inventory control, and monitoring throughout pharmaceutical logistics operations.

Specialized Pharmaceutical Transportation: Secure and compliant transportation solutions are becoming increasingly important for maintaining product quality, safety, and controlled environmental conditions, while third-party logistics providers are expanding integrated transportation, warehousing, inventory management, and distribution capabilities.

Cold-Chain Logistics and Digital Tracking Drive Global Pharmaceutical Logistics Market Segmentation Insights

Global Pharmaceutical Logistics Market by Service, Type, and Application is strategically shaped by the growing demand for transportation, warehousing, distribution, inventory management, and temperature-controlled logistics across pharmaceutical supply chains. Increasing volumes of biologics, vaccines, specialty medicines, and temperature-sensitive products are strengthening demand for cold-chain transportation, specialized warehousing, and real-time monitoring. At the same time, IoT-enabled monitoring, GPS tracking, digital shipment visibility, and track-and-trace systems are improving pharmaceutical logistics efficiency, traceability, and regulatory compliance.

By Service

Transportation

Warehousing

Distribution

Inventory Management

Order Fulfillment

Value-Added Services

By Type

Cold Chain Logistics

Non-Cold Chain Logistics

By Application

Pharmaceutical Manufacturing

Biologics and Specialty Medicines

Vaccines

Clinical Trial Materials

Other Pharmaceutical Products

Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/checkout/108428/

North America Leads While Asia-Pacific Expands: Key Regional Insights Driving Global Pharmaceutical Logistics Market

North America is a significant region in the Global Pharmaceutical Logistics Market, supported by its established pharmaceutical and biotechnology industries, advanced healthcare infrastructure, sophisticated distribution networks, and developed cold-chain capabilities. Growing demand for biologics, specialty medicines, vaccines, and clinical trial materials is increasing the need for validated cold-chain transportation, specialized warehousing, real-time shipment monitoring, and compliant pharmaceutical distribution. The expanding role of third-party logistics providers and digital supply-chain technologies is further strengthening regional logistics capabilities.

Asia-Pacific is emerging as an important growth center in the Global Pharmaceutical Logistics Market, supported by expanding pharmaceutical manufacturing, rising healthcare expenditure, increasing pharmaceutical exports, and developing distribution infrastructure. China and India are major contributors, while Japan, South Korea, Singapore, and Australia are supporting regional logistics development. Growing demand for biologics, vaccines, specialty pharmaceuticals, temperature-controlled transportation, specialized warehousing, and digitally monitored supply chains is creating significant Pharmaceutical Logistics Market Growth Opportunities across the region.

DHL Supply Chain, UPS Healthcare & FedEx Drive Global Pharmaceutical Logistics Market with Cold-Chain and Digital Logistics Innovations

DHL Supply Chain is strengthening its pharmaceutical logistics capabilities through expanded cold-chain infrastructure, healthcare facilities, dedicated solutions for biologics, vaccines, and advanced therapies, along with digital monitoring and temperature-controlled logistics.

UPS Healthcare is expanding temperature-controlled infrastructure and specialized handling capabilities for pharmaceutical and complex healthcare products, strengthening cold-chain connectivity and reliable distribution across healthcare supply chains.

FedEx is strengthening its life-sciences logistics capabilities for medicines, biologics, medical devices, and clinical trial materials through specialized handling and certified pharmaceutical transportation solutions.

Helping Advance Industry Collaboration, Innovation and the Future of Global Supply Chains

SEOUL, South Korea and TEANECK, N.J., Sept. 21, 2026 /PRNewswire/ -- LX Pantos Americas is proud to announce its Regional Sponsorship and participation in the VMA26 International Trade Symposium, a premier industry event that brings together business leaders, innovators and supply chain professionals to explore the trends, challenges and opportunities shaping the future of global trade and maritime commerce. The event will take place October 13-15 at the Hilton Norfolk The Main in Norfolk, Virginia.

LX Pantos Americas' participation in VMA26 reflects the company's deep commitment to maritime transportation and growing investment in Virginia as a strategic gateway for global trade. The company has strengthened its presence in the Commonwealth through recent Memorandums of Understanding with The Port of Virginia and the Virginia Economic Development Partnership (VEDP), reinforcing a shared focus on trade growth, supply chain innovation and economic development. These relationships position LX Pantos Americas to support customers with enhanced connectivity and logistics solutions while contributing to Virginia's role as a leading hub for international commerce.

As economic ties between the United States and Korea continue to expand, LX Pantos Americas is closely aligned with the opportunities emerging from increased Korean investment across North American manufacturing, infrastructure and transportation networks. The company is actively evaluating opportunities related to the anticipated $150 billion shipbuilding collaboration initiative between the U.S. and Korea and the broader supply chain ecosystem it is expected to support. LX Pantos Americas will host a private executive roundtable during VMA26, bringing together business and supply chain leaders to explore how strategic investment, collaboration and resilient infrastructure can be leveraged to create long-term competitive advantage in a rapidly evolving global marketplace.

LX Pantos Americas CEO David Bang will participate in Late Night Freight on Thursday, October 15, at 11:15 a.m. with host Eric Jehu, VP, Logistics for the VEDP, where he provides primary staff leadership for developing and implementing strategies to promote employment growth within Virginia's logistics industry. The session will bring together leaders from the legal, pharmaceutical and logistics sectors to discuss the policy, infrastructure and investment priorities shaping the future of supply chains. Bang will share LX Pantos Americas' "supply chain forward" perspective, emphasizing the importance of collaboration, strategic investment and policy alignment in building resilient supply chains and supporting sustainable industry growth.

Reflecting its commitment to fostering future industry talent, LX Pantos Americas will sponsor a student's participation in VMA26 and welcome a student guest to its sponsored table at the Maritime Banquet, helping connect emerging professionals with industry leaders while supporting the next generation of maritime, logistics and international trade talent.

"Virginia continues to play an increasingly important role in global trade, making VMA26 an ideal forum to discuss the opportunities created by growing investment and collaboration across the supply chain ecosystem," said David Bang, CEO of LX Pantos Americas. "As economic ties between the United States and Korea deepen, we see significant potential to strengthen maritime transportation, infrastructure and logistics networks. Through our partnerships in Virginia and engagement with industry leaders at VMA26, we look forward to contributing to conversations that help transform investment into long-term economic growth and supply chain resilience."

- About LX Pantos Americas

LX Pantos Americas is the Americas regional organization of LX Pantos, a leadingglobal logistics company. With operations spanning across North and South America, LX Pantos Americas combines global scale and standards with deep regional expertise and local execution excellence. The company delivers optimized, end-to-end logistics solutions tailored to support business growth across a wide range of industries, while actively contributing to the communities it serves. LX Pantos Americas brings customers closer to their end markets faster, through all modes of transportation and contract logistics capabilities, including last mile delivery and installation services offered through InstallX, leveraging deep expertise and advanced technical knowledge. The company's StarLinks service provides reliable and competitive ground transportation solutions across North America powered by its partners and BoxLinks – an innovative joint venture with a major ocean shipping line – enhancing intermodal transport solutions. Driven by a strong dedication to service excellence and client success, LX Pantos Americas helps customers move forward with confidence. Learn more about LX Pantos Americas online and follow it on LinkedIn.

- About LX Pantos

Established in 1977, LX Pantos is a leading global logistics provider headquartered in Korea. It delivers comprehensive logistics solutions across sea, air, rail, and contract logistics through a worldwide network spanning more than 40 countries.

Learn more about LX Pantos online and follow it on LinkedIn.

SOURCE LX Pantos

Share this article

Guarantor Platform Helps Properties Approve Qualified Renters as Concessions Climb and Rents Fall

PHOENIX, Sept. 21, 2026 /PRNewswire/ -- Cosign, a third-party guarantor platform and cosigner alternative designed to expand renter access while protecting property owners, has launched in the Phoenix-Mesa-Chandler MSA as the Valley works through some of the highest apartment vacancy in the country.

According to CoStar, apartment vacancy across Maricopa County and the broader Phoenix-Mesa-Chandler MSA sits at 10.8%, still near the highest level since the Great Recession despite improving from a peak of 12.6%. The metro ranks among the nation's top 10 highest-vacancy markets, alongside fellow Sun Belt builders like Austin, Charlotte and San Antonio. Asking rents fell 1.2% over the past year, and operators are leaning harder on concessions, with 10 or more weeks of free rent now common at newly built communities.

At Zendoor, a Phoenix-based multifamily property management company, the team has adopted Cosign to help streamline apartment approval for renters who can afford the rent but get screened out by rigid legacy criteria.

"At Zendoor, we're seeing that many renters who may not meet traditional screening criteria can still be responsible, qualified residents," said Jessa Mae, the resident support team lead at Zendoor. "Having flexible solutions that give these applicants another path to approval can help property managers reduce unnecessary denials while making it easier to fill homes across the Phoenix market."

Founded by real estate owners and operators, Cosign uses a data-driven underwriting model that evaluates payment behavior and recency rather than relying solely on credit scores. The platform is designed to help owners fill units faster without lowering standards, a case that matters most in markets like Phoenix where every leased unit counts against a deep supply overhang.

"Phoenix is a market where owners can't afford to lose a qualified renter over a technicality," said Zach Schofel, co-founder and CEO of Cosign. "When vacancy is this high, the properties that win are the ones saying yes to renters who can actually pay, and that's exactly what we help them do."

For more information, visit www.rentwithcosign.com and follow on social media @rentwithcosign.

About Cosign

Cosign is a real estate technology company and lease guarantor service that bridges the gap between qualified renters and landlords. Founded by real estate professionals, Cosign's mission is to expand housing access through data-driven underwriting that considers payment behavior, not just credit scores. Active in more than 600,000 units across 3,000+ communities nationwide, Cosign is helping modern operators approve more qualified renters in both tight and oversupplied markets. For more information, visit www.rentwithcosign.com.

SOURCE Cosign

Share this article

New PrSM demonstrates moving target engagement expanding the U.S. Army's mission set

DALLAS, Sept. 21, 2026 /PRNewswire/ -- The U.S. Army has awarded Lockheed Martin (NYSE:LMT) an indefinite delivery, indefinite quantity (IDIQ) contract worth up to $1.2 billion to produce Increment 2 of the Precision Strike Missile (PrSM), further strengthening the nation's Arsenal of Freedom after a second flight test demonstrated the missile's ability to engage moving maritime targets.

THE BIG PICTURE

- Contract: The IDIQ covers initial procurement and future orders of PrSM Increment 2 missiles, follow-on production and continued development. Work will be performed at Lockheed Martin facilities and across the company's U.S. industrial base.

- Test: PrSM Increment 2 completed its first flight test in March and its second flight test in August – obtaining critical data during flight, launching from a HIMARS, deploying protective covers and engaging the target. Technologies developed through Lockheed Martin's Strigo family of solutions have informed aspects of the PrSM Increment 2 guidance package. Additional PrSM Increment 2 flight tests are scheduled for 2027.

- Investment: This award builds on the Department of War's broader investment in PrSM. Lockheed Martin is expanding capacity to quadruple PrSM production while continuing to develop additional PrSM increments.

WHY IT MATTERS

The award moves PrSM Increment 2 from development and flight testing into production, advancing the Army's next-generation long-range precision fires capability. Increment 2 adds a multimode seeker designed to enable the missile to engage moving land and maritime targets, expanding the Army's long-range strike options.

EXPERT PERSPECTIVE

- "This award marks an important step in delivering PrSM Increment 2 to the warfighter," said Dave Griser, vice president, Precision Fires Launchers and Missile, Lockheed Martin. "We're ready to move from flight testing into production and provide the Army with an expanded long-range precision fires capability."

ADDITIONAL CONTEXT

- What's Next: Lockheed Martin will begin production of the initial Increment 2 missiles while continuing flight testing and system maturation. The company is positioned to scale production as the Army moves toward larger Increment 2 procurements.

About Lockheed Martin

Lockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Our all-domain mission solutions and 21st Century Security® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of ready. More information at Lockheedmartin.com. 

SOURCE Lockheed Martin

Share this article